• 1. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 2. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 3. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 4. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 5. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Phenyl-1,3-oxazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Oxazoles Phenyl-1,3-oxazoles

Recent Advances in the Study of 4-(Chloromethyl)-5-methyl-2-(4-methylphenyl)-1,3-oxazole (CAS: 137090-44-9)

The compound 4-(Chloromethyl)-5-methyl-2-(4-methylphenyl)-1,3-oxazole (CAS: 137090-44-9) has recently garnered significant attention in the field of chemical biology and medicinal chemistry due to its potential applications in drug discovery and development. This oxazole derivative is a key intermediate in the synthesis of various bioactive molecules, particularly those targeting inflammatory and oncological pathways. Recent studies have explored its reactivity, pharmacological properties, and utility in the design of novel therapeutic agents.

One of the most notable advancements in the study of this compound is its role as a building block for the synthesis of kinase inhibitors. Kinases are critical regulators of cellular processes, and their dysregulation is implicated in numerous diseases, including cancer. Researchers have demonstrated that modifications to the oxazole core of 137090-44-9 can yield compounds with high selectivity and potency against specific kinase targets. For instance, a 2023 study published in the Journal of Medicinal Chemistry highlighted the successful incorporation of this oxazole derivative into a series of EGFR (epidermal growth factor receptor) inhibitors, showing promising anti-tumor activity in preclinical models.

In addition to its applications in oncology, 4-(Chloromethyl)-5-methyl-2-(4-methylphenyl)-1,3-oxazole has been investigated for its anti-inflammatory properties. A recent study in Bioorganic & Medicinal Chemistry Letters reported that derivatives of this compound exhibit significant inhibitory effects on the production of pro-inflammatory cytokines, such as TNF-α and IL-6. These findings suggest its potential as a scaffold for developing new anti-inflammatory drugs, particularly for conditions like rheumatoid arthritis and inflammatory bowel disease.

The synthetic versatility of 137090-44-9 has also been a focus of recent research. Advances in green chemistry have led to the development of more efficient and environmentally friendly methods for its synthesis. For example, a 2022 paper in Organic Process Research & Development described a catalyst-free, one-pot synthesis of this oxazole derivative under mild conditions, significantly improving yield and reducing waste. Such innovations are critical for scaling up production and ensuring the sustainability of pharmaceutical manufacturing processes.

Despite these promising developments, challenges remain in the optimization of 4-(Chloromethyl)-5-methyl-2-(4-methylphenyl)-1,3-oxazole-based therapeutics. Issues such as bioavailability, metabolic stability, and off-target effects need to be addressed through further structural modifications and in-depth pharmacological studies. However, the compound's unique chemical properties and demonstrated bioactivity make it a valuable candidate for continued exploration in drug discovery.

In conclusion, recent research on 137090-44-9 underscores its potential as a versatile and pharmacologically relevant scaffold in medicinal chemistry. Ongoing studies are expected to further elucidate its mechanisms of action and expand its applications in the treatment of various diseases. The integration of computational modeling and high-throughput screening techniques will likely accelerate the discovery of new derivatives with enhanced therapeutic profiles.

• 832076-93-4(Oxazole, 4-(chloromethyl)-2-(3,4-dichlorophenyl)-5-methyl-)
• 122994-69-8(4-(Chloromethyl)-2-(4-methoxyphenyl)-5-methyl-1,3-oxazole)
• 103788-61-0(4-Chloromethyl-5-methyl-2-phenyl-oxazole)
• 832076-94-5(Oxazole, 4-(chloromethyl)-2-(2,4-dichlorophenyl)-5-methyl-)
• 1283892-96-5(4-(Chloromethyl)-2-(2,5-dimethylphenyl)-5-methyl-1,3-oxazole)
• 328918-94-1(2-(3-Bromophenyl)-4-(chloromethyl)-5-methyl-1,3-oxazole)
• 832076-92-3(Oxazole, 4-(chloromethyl)-2-(4-chlorophenyl)-5-methyl-)
• 671215-81-9(4-(chloromethyl)-5-methyl-2-(2-methylphenyl)-1,3-oxazole)
• 832076-91-2(Oxazole, 2-[1,1'-biphenyl]-4-yl-4-(chloromethyl)-5-methyl-)
• 625826-69-9(4-Chloromethyl-2-(4-fluoro-phenyl)-5-methyl-oxazole)